Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron D Bossler

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Carcinogenesis|June 23, 2009
Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1Michael J Lace, James R Anson, Aloysius J Klingelhutz, et al.
Cancer Cytopathology|January 25, 2018
Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assayNatalya V Guseva, Omar Jaber, Aaron A Stence, et al.
Cancer Genetics|June 14, 2016
The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencingNatalya V Guseva, Munir R Tanas, Aaron A Stence, et al.
Pathology, Research and Practice|April 17, 2024
Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtypeBilge Dundar, Mouaz Alsawas, Amr Masaadeh, et al.
Head & Neck|July 28, 2007
Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cellsWilliam C Spanos, Jeremy Geiger, Mary E Anderson, et al.
The Journal of Molecular Diagnostics : JMD|August 13, 2021
Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular DystrophyAaron A Stence, Jon G Thomason, Jonathan A Pruessner, et al.
Oncotarget|November 29, 2017
Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb studyYousef Zakharia, Varun Monga, Umang Swami, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphomaBrian K Link, Zuhair K Ballas, Daniel Weisdorf, et al.
Genes, Chromosomes & Cancer|December 3, 2016
Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cystNatalya V Guseva, Omar Jaber, Munir R Tanas, et al.
Journal of Virology|December 28, 2007
The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growthWilliam C Spanos, Andrew Hoover, George F Harris, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Carcinogenesis|June 23, 2009
Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1Michael J Lace, James R Anson, Aloysius J Klingelhutz, et al.
Cancer Cytopathology|January 25, 2018
Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assayNatalya V Guseva, Omar Jaber, Aaron A Stence, et al.
Cancer Genetics|June 14, 2016
The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencingNatalya V Guseva, Munir R Tanas, Aaron A Stence, et al.
Pathology, Research and Practice|April 17, 2024
Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtypeBilge Dundar, Mouaz Alsawas, Amr Masaadeh, et al.
Head & Neck|July 28, 2007
Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cellsWilliam C Spanos, Jeremy Geiger, Mary E Anderson, et al.
The Journal of Molecular Diagnostics : JMD|August 13, 2021
Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular DystrophyAaron A Stence, Jon G Thomason, Jonathan A Pruessner, et al.
Oncotarget|November 29, 2017
Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb studyYousef Zakharia, Varun Monga, Umang Swami, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphomaBrian K Link, Zuhair K Ballas, Daniel Weisdorf, et al.
Genes, Chromosomes & Cancer|December 3, 2016
Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cystNatalya V Guseva, Omar Jaber, Munir R Tanas, et al.
Journal of Virology|December 28, 2007
The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growthWilliam C Spanos, Andrew Hoover, George F Harris, et al.
Pageof 4